1-3 of 3
Wenan Qiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts

Vania Vidimar, Minyoung Park, Caleb K. Stubbs, Nana K. Ingram, Wenan Qiang, Shanshan Zhang, Demirkan Gursel, Roman A. Melnyk, Karla J.F. Satchell
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (5): 810–820.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0550
Published: 04 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C012: Real-world use of circulating tumor DNA (ctDNA) in the clinical management of patients with solid tumors: A single institution’s experience

Amir Behdad, Firas Wehbe, Carmen Williams, Wenan Qiang, Athanasios Vasilopoulos, Massimo Cristofanilli MD FACP
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C012.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-C012
Published: 01 December 2019
View article
Journal Articles

Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An In Vivo Study in Orthotopic Xenografts of Nude Mice

Xiaofei Xu, Bushra Ayub, Zhaojian Liu, Vanida Ann Serna, Wenan Qiang, Yugang Liu, Eva Hernando, Sonya Zabludoff, Takeshi Kurita, Beihua Kong, Jian-Jun Wei
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (7): 1729–1739.
DOI: https://doi.org/10.1158/1535-7163.MCT-13-0982
Published: 06 July 2014
View article
PDF
Includes: Supplementary data